MID1 and kidney disorder: Thus, further validation of the upstream and downstream relationship between TRIM29/TRIM18 and STING in various renal diseases is necessary to determine whether TRIM29/TRIM18 can effectively regulate STING, thereby controlling acute and chronic kidney injury, as well as renal cancer.